The purpose of this study are to obtain learnings regarding the Digital Therapeutic (DTx) experience of Clickotine, including acceptability and preference of the overall program and specific DTx components, as well as to obtain learnings related to adult participants' use of the DTx for smoking cessation.
Study Type
OBSERVATIONAL
Enrollment
78
Clickotine is a DTx that contains behavior modification techniques that include controlled breathing, social engagement, personalized messaging, medication access and adherence, digital diversions, and financial incentives.
Click Therapeutics
New York, New York, United States
The main outcome of the Clickotine Learning Study is to determine acceptability of the digital intervention (DTx).
General acceptability of the DTx will be evaluated via surveys for all participants
Time frame: 4 Months
The main outcome of the Clickotine Learning Study is to determine engagement with the digital intervention (DTx).
Engagement with the digital intervention will be measured via app use for all participants
Time frame: 4 Months
The main outcome of the Clickotine Learning Study is to evaluate attitudes and beliefs regarding the digital intervention.
Attitudes and beliefs regarding the digital intervention will be evaluated by interview for selected participants
Time frame: 4 Months
The secondary outcome of the Clickotine Learning Study is to measure engagement levels with the digital intervention for cigarette smokers as compared to dual-users
These engagement levels will be measured via app use.
Time frame: 4 Months
The secondary outcome of the Clickotine Learning Study is to determine acceptability of the digital intervention for cigarette users as compared to dual-users
Acceptability of the digital intervention will be evaluated via survey
Time frame: 4 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.